IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
about
IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradationRole of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis throughCellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcriptionThe USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4)Effects of Brassicaceae Isothiocyanates on Prostate CancerNF-κB, the first quarter-century: remarkable progress and outstanding questionsInhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammationSmall-molecule SMAC mimetics as new cancer therapeuticsNOD-Like Receptors: Master Regulators of Inflammation and CancerRole of apoptosis in diseaseAberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic targetIs there a molecular logic that sustains neuronal functional integrity and survival? Lipid signaling is necessary for neuroprotective neuronal transcriptional programsRegulation of cell death by transfer RNAGetting TRAIL back on track for cancer therapyStructural mechanisms of DIAP1 auto-inhibition and DIAP1-mediated inhibition of drICEHelical Repeat Structure of Apoptosis Inhibitor 5 Reveals Protein-Protein Interaction ModulesA1/Bfl-1 in leukocyte development and cell deathAnalysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.UBXD Proteins: A Family of Proteins with Diverse Functions in CancerDepletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survivalNeuroprotection by epigallo catechin gallate against bupivacaine anesthesia induced toxicity involves modulation of PI3/Akt/PTEN signalling in N2a and SH-SY5Y cellsA small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cellsResveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell developmentImatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicityCompound A398, a novel podophyllotoxin analogue: cytotoxicity and induction of apoptosis in human leukemia cellsCausal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular CarcinomaA Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma VirusesSurvivin Is a transcriptional target of STAT3 critical to estradiol neuroprotection in global ischemiaFAIM-L regulation of XIAP degradation modulates Synaptic Long-Term Depression and Axon DegenerationThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.Evolutionary conservation of infection-induced cell death inhibition among Chlamydialesc-IAP1 and c-IAP2 redundancy differs between T and B cells.Identification of new IκBα complexes by an iterative experimental and mathematical modeling approach.Polyclonal rabbit anti-human ovarian cancer globulins inhibit tumor growth through apoptosis involving the caspase signaling.Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.MicroRNA-135a-3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer.cIAP2 promotes gallbladder cancer invasion and lymphangiogenesis by activating the NF-κB pathway.
P2860
Q24298339-3F26E158-735E-4DFB-B499-DC7F5D519B40Q24299363-856C6B8F-E74D-44F4-9193-D72B2148CBBBQ24306110-19B6AD39-71AC-456E-ABD9-4A6E469BCDC3Q24323126-98E9E864-FF4C-42CC-8E59-60F8C2ECF2A8Q24338276-0D9A6DA9-B0D9-4AF5-B8E3-82D118D9ABCDQ26749086-BA971738-085B-4286-8D2D-9E9223E7C506Q26822516-010A0218-7A82-441F-9BC8-D6EBCFCDD0ECQ26824586-DBA0530E-1F7A-4F7D-B7D4-7D63E30612BFQ26864204-87495FCB-4C94-4584-A0E1-DA145B33BF92Q26865199-86CECD7B-00B2-47BA-AC37-EC3813196112Q26865637-89000631-9EA1-42EA-9B49-35431B93B4AEQ26995561-14F7FEFC-7142-4613-A913-5DBC474EE5D2Q26996617-7BCC257A-DA59-4C45-B7AC-85DE5E2241DBQ27003645-FCCE73A8-3406-44AE-B71D-91D14DADD013Q27027460-36BF1AE5-C55E-42CF-AA30-901ED08EA148Q27671407-626EBFCF-7DEB-4739-92C2-B151E3DECE60Q27677281-D9E8BD4A-19AF-4885-AFB1-DD7AB0EBBD45Q27691571-8941EDD5-548B-4827-8844-0EDB2C459209Q27851655-59B2AD74-7FE7-4378-9493-76BB6ED7DEF7Q27851964-217CF0C4-FD46-47E1-87A2-FEABC6AF80D6Q28069036-112E2108-163C-4C34-ACC3-4C0312DE5159Q28249358-7B93AA25-4F81-4F3B-B077-91A10F9800EEQ28394702-FBB4BA37-BCC8-4308-B9F3-23DA5D93D5CAQ28482952-28168045-FDC4-4464-84A0-83CB515E16E4Q28483748-96EB30E0-04A8-425B-ABB7-DB9CE9D5FC72Q28485861-1A9F4CA5-50E9-4DAA-8E1F-030B9152DA64Q28540934-35C23AF7-407B-427C-948B-8F00C139AF32Q28542976-515250E8-8A30-430D-815F-FB214A818C13Q28547556-5E5977EB-C769-45AF-B3F0-FABC2A25F589Q28550190-AEC2E13F-627E-42DB-BC0A-767B79CBC9C2Q28573165-7AAB677A-3F8D-47CA-A459-9B28CC78D936Q28821419-6F10FFB8-D00E-4324-A938-928C7C08ECF2Q30486745-3AFF3131-E824-4E9E-99C0-6275BB244F9FQ31028231-EAA38842-D2EC-4F2D-8D9C-3814A5F53E55Q31120747-5CEF18C2-2718-46B5-A8F9-511211261A99Q31154854-BDDC50C4-E2AC-4A88-9F22-C2BC6727D76BQ33612686-DCCBD671-9456-456A-8E9F-0C7E03AB6AFDQ33624824-EA8E4D9A-4218-46A3-9701-62F5EC38EF2AQ33738954-EB69E4D1-0AF6-45AF-8B81-0C1DD41D819DQ33823297-680124CB-AB96-406B-BB99-2FC575E8DCA5
P2860
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@ast
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@en
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@en-gb
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@nl
type
label
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@ast
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@en
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@en-gb
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@nl
prefLabel
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@ast
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@en
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@en-gb
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@nl
P921
P3181
P356
P1476
IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer
@en
P2888
P304
P3181
P356
10.1038/NRC2889
P407
P577
2010-08-01T00:00:00Z
P5875
P6179
1029088561